Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.23.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]      
Net sales $ 157,118 $ 122,814 $ 97,489
Cost of products sold 131,710 113,685 77,020
Gross profit 25,408 9,129 20,469
Other expenses and income:      
Selling, general and administrative 23,063 20,386 17,471
Selling, general and administrative – amortization 1,095 913 0
Other operating (income) expense, net 0 (827)  
Operating income (loss) 1,250 (11,343) 2,998
Other income (250) (527) (113)
Interest income (129) (50) (167)
Interest expense 1,068 450 11
Total other expenses and income 689 (127) (269)
Income (loss) before provision (benefit) for income taxes 561 (11,216) 3,267
Provision (benefit) for income taxes 194 (2,443) 893
Net income (loss) $ 367 $ (8,773) $ 2,374
Basic:      
Net income (loss) $ 0.03 $ (0.83) $ 0.24
Diluted:      
Net income (loss) $ 0.03 $ (0.83) $ 0.24
Average common shares outstanding:      
Basic 10,614 10,541 9,959
Diluted 10,654 10,541 9,959
Dividends declared per share $ 0 $ 0.33 $ 0.44